BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11811941)

  • 1. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid.
    Yang Q; Abedi-Valugerdi M; Xie Y; Zhao XY; Möller G; Nelson BD; DePierre JW
    Int Immunopharmacol; 2002 Feb; 2(2-3):389-97. PubMed ID: 11811941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice.
    Yang Q; Xie Y; Eriksson AM; Nelson BD; DePierre JW
    Biochem Pharmacol; 2001 Oct; 62(8):1133-40. PubMed ID: 11597582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of peroxisome proliferators PFOA on immune system of mice].
    Yang J; Li A; Yang Q; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):157-60. PubMed ID: 16507247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice.
    Yang Q; Xie Y; Alexson SE; Nelson BD; DePierre JW
    Biochem Pharmacol; 2002 May; 63(10):1893-900. PubMed ID: 12034374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice.
    Xie Y; Yang Q; Nelson BD; DePierre JW
    Biochem Pharmacol; 2003 Sep; 66(5):749-56. PubMed ID: 12948855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.
    DeWitt JC; Williams WC; Creech NJ; Luebke RW
    J Immunotoxicol; 2016; 13(1):38-45. PubMed ID: 25594567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peroxisome proliferators on the thymus and spleen of mice.
    Yang Q; Xie Y; Depierre JW
    Clin Exp Immunol; 2000 Nov; 122(2):219-26. PubMed ID: 11091278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes.
    Okochi E; Nishimaki-Mogami T; Suzuki K; Takahashi A
    Biochim Biophys Acta; 1999 Mar; 1437(3):393-401. PubMed ID: 10101272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice.
    Dewitt JC; Copeland CB; Strynar MJ; Luebke RW
    Environ Health Perspect; 2008 May; 116(5):644-50. PubMed ID: 18470313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells.
    Shabalina IG; Panaretakis T; Bergstrand A; DePierre JW
    Carcinogenesis; 1999 Dec; 20(12):2237-46. PubMed ID: 10590214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hepatic peroxisome proliferation by 8-2 telomer alcohol feeding in mice: formation of perfluorooctanoic acid in the liver.
    Kudo N; Iwase Y; Okayachi H; Yamakawa Y; Kawashima Y
    Toxicol Sci; 2005 Aug; 86(2):231-8. PubMed ID: 15888668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotoxicity and allergenic potential induced by topical application of perfluorooctanoic acid (PFOA) in a murine model.
    Shane HL; Baur R; Lukomska E; Weatherly L; Anderson SE
    Food Chem Toxicol; 2020 Feb; 136():111114. PubMed ID: 31904477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats.
    Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
    Cancer Lett; 1991 Apr; 57(1):55-60. PubMed ID: 2025879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion.
    Qazi MR; Bogdanska J; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicology; 2009 Aug; 262(3):207-14. PubMed ID: 19540903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferation and associated effects caused by perfluorooctanoic acid in vitamin A-deficient mice.
    Sohlenius AK; Andersson K; Olsson J; DePierre JW
    Chem Biol Interact; 1995 Oct; 98(1):45-50. PubMed ID: 7586050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver.
    Sohlenius AK; Lundgren B; DePierre JW
    J Biochem Toxicol; 1992; 7(4):205-12. PubMed ID: 1293309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
    Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
    Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone.
    Ladics GS; Kawabata TT; White KL
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):31-44. PubMed ID: 1908145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 1-thiocarbamoyl-2-imidazolidinone on the generation of plaque forming cell responses.
    Sissors DL; Gautam SC; Webster LT
    Int J Immunopharmacol; 1985; 7(2):177-85. PubMed ID: 3159691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can sustained exposure to PFAS trigger a genotoxic response? A comprehensive genotoxicity assessment in mice after subacute oral administration of PFOA and PFBA.
    Crebelli R; Caiola S; Conti L; Cordelli E; De Luca G; Dellatte E; Eleuteri P; Iacovella N; Leopardi P; Marcon F; Sanchez M; Sestili P; Siniscalchi E; Villani P
    Regul Toxicol Pharmacol; 2019 Aug; 106():169-177. PubMed ID: 31071380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.